Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age70+
SponsorRenJi Hospital
About this trial
The goal of this observational study is to learn about the impact of chemotherapy-related toxicity on older cancer patients in China. The main question it aims to answer is:
Does the Cancer and Aging Research Group (CARG) chemotherapy toxicity risk score predict chemotherapy-related toxicity in Chinese cancer patients over age 70? Participants over age 70 on systemic chemotherapy will answer questions listed in the CARG chemotherapy toxicity risk tool.
Eligibility criteria
Qualifiers
Age≥ 70 years old
Confirmed diagnosis of solid tumor (any stage)
ECOG-PS score 0-2 points
Admission to the hospital for a new chemotherapy regimen (initial or change)
Disqualifiers
Patients who are on immunotherapy and/or targeted therapy only
Patients with hematologic malignancy
Patients with severe infections (sepsis, severe respiratory tract infections, severe urinary tract infections, severe abdominal infections, etc.).
Patients with severe heart, liver, and kidney dysfunction or failure
Trial design
Treatments tested in this trial
- Chemotherapy
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov